Page related to the project Gender Difference in sidE eFfects of ImmunNotherapy: a possibile clue to optimize cancEr tReatment (G-DEFINER)
Milano, Lombardia
Joined March 2020
- Tweets55
- Following28
- Followers7
- Likes172
G-DEFINER retweeted
#Postdoc position available on #sarcoma #Immunity at Molecular Pharmacology of @IstTumori - if interested please contact [email protected]
G-DEFINER retweeted
Yes; categorization completely arbitrary; quintiles are demographic not biologic; hides any steep part of the risk curve. Outer quintiles are very heterogeneous. Show the risk curve as a function of relative food volume. #bbrcourse #rmscourse discourse.datamethods.org/t/…
G-DEFINER retweeted
Interesting discussion about adjuvant treatment in extremity STS at ISG annual meeting…food for thoughts and new idea for an upcoming trial! Stay tuned…@alegronchi @annamariafrezza @SilviaStacchia @casali_pg @apdeitos @sandro_pasquali @Robertasanfili @ctosociety – at Rozzano, Lombardia
G-DEFINER retweeted
Abstract submission is now open for #BRIDGES2022!
The conference BRIDGES BETWEEN DISCIPLINES: GENDER IN STEM AND SOCIAL SCIENCES is a hybrid (on-site + online) event to be held on September 12-16, 2022. More information: bridges2022.com/registration…
#Intersectionality #GenderBias
G-DEFINER retweeted
@GDefiner identifying how gender plays a role in how people have adverse immune related events associated with their immunotherapy.
G-DEFINER retweeted
Congratulations to @ProfJohnCrown on this recognition of his achievements in the field of cancer research. #DCUPresidentAwards Prof. Crown is also involved in a @GENDER_NET_Plus project on gender difference in side effects of immunotherapy, supported by @IrishResearch
Prof John Crown @ProfJohnCrown is the next recipient of #DCUPresidentAwards in Research & Impact for the ‘Research in CCRT team results in launching of CAROLINE-1 Clinical Trial’. Prof Crown is the Baldwin Chair of Translation Medicine at DCU #DCUResearch @DCU_Research @nicb_dcu
G-DEFINER retweeted
As the City begins to reopen, our communities will have collective and individual needs. Join @GenderEquityNYC tomorrow at 2PM to learn how experts in the City are providing support to girls, women, transgender and gender non-binary New Yorkers: bit.ly/GenderEquityCOVIDTown…
G-DEFINER retweeted
Dr. Trent discusses some of the recent immunotherapeutic advances in the treatment landscape for patients with sarcoma, particularly with immune checkpoint inhibitors.
targetedonc.com/videos/immun… #sarcomas #sksm
G-DEFINER retweeted
Press release from #SICO #AIOM #AIRO
Italian Oncologic Societies are working together to give best support to Italian patients during Covid-19 emergency @SICOBoard @AIOMtweet @AiomFondazione @AIRO80327989 @alegronchi @SCinieri
sicoweb.it/covid.pdf
G-DEFINER retweeted
Celebrating #IWD2020 and the great G-DEFINER team who are working towards understanding the impact of Gender on response to #immunoncology agents in the treatment of cancer @IrishResearch @gendernet #eachforequal #loveirishresearch @ProfJohnCrown
G-DEFINER retweeted
G-DEFINER is a project funded by Gender-NET Plus. In the International Women's Day, G-DEFINER team encourages gender research, the benefits of which are not just for women but “for everyone whose lives will be changed by a fairer world” #IWD2020 #eachforequal #loveirishresearch
G-DEFINER retweeted
Today is the International Women's Day.
G-DEFINER is a project funded by Gender-NET Plus facebook.com/gendernet.plus.…
investigating the differences in sex and gender in adverse effects of immunnotherapy administered in different types of cancers. @ProfJohnCrown @svuh @CCRTIreland
G-DEFINER retweeted
On International Women's Day, the G-DEFINER team strongly encourage gender research, the benefits of which are not just for women and girls, but “for everyone whose lives will be changed by a fairer world”
#IWD2020 #eachforequal #loveirishresearh #Cancer